Dr Reddys Laboratories RDY
NYSE RDY
$12.26 -0.36 (-2.85%)
As of: Oct 1, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Non Operating Income (2009 - 2010)

Updated

Dr Reddys Laboratories' Non Operating Income came in at -$2 million for the quarter ended Dec 31, 2010.

Analysis

Dr Reddys Laboratories (RDY) Non Operating Income (2009 - 2010) Analysis & Trends

  • The figure for the quarter ended Dec 31, 2010 represents the lowest quarterly Non Operating Income since the quarter ended Jun 30, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Dr Reddys Laboratories 10.53 Bn 9.72 Bn 396.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 -2.00 Mn
Jun 30, 2009 -3.00 Mn
API Access

Dr Reddys Laboratories Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=RDY&period=max&api_key=YOUR_API_KEY